Atrium Therapeutics, Inc.RNANASDAQ
Loading
| Metric | Dec 25 |
|---|---|
| Revenue | 19 |
| Gross Profit | 19 |
| Operating Income | -77 |
| Net Income | -77 |
| EBITDA | -76 |
| EPS Diluted | -4.48 |
| Metric | Dec 25 |
|---|---|
| Cash & Equivalents | 270 |
| Total Current Assets | 273 |
| Total Assets | 278 |
| Total Current Liabilities | 42 |
| Total Liabilities | 71 |
| Total Equity | 207 |
| Total Debt | 4 |
| Net Debt | -266 |
| Metric | Dec 25 |
|---|---|
| Operating Cash Flow | -41 |
| Capital Expenditure | -1 |
| Free Cash Flow | -43 |
| Stock-Based Comp | 8 |
| Net Change in Cash | 0 |